Is NPCE or RCEL more profitable?

NeuroPace has a net margin of -21.67% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat NeuroPace's return on equity. Company Net Margins Return on Equity Return on Assets NeuroPace -21.67% -108.20% -18.50% Avita Medical -62.67% N/A -78.92%

Avita Medical (RCEL) Competitors

$4.06 -0.35 (-7.94%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$4.07 +0.01 (+0.12%)

As of 07/10/2026 04:10 PM Eastern

Compare

RCEL vs. BWAY, MDXG, NPCE, CLPT, and KIDS

Should you buy Avita Medical stock or one of its competitors? MarketBeat compares Avita Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Avita Medical include Brainsway (BWAY), MiMedx Group (MDXG), NeuroPace (NPCE), ClearPoint Neuro (CLPT), and OrthoPediatrics (KIDS). These companies are all part of the "medical equipment" industry.

How does Avita Medical compare to Brainsway?

Avita Medical (NASDAQ:RCEL) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Brainsway has lower revenue, but higher earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.75	-$48.59M	-$1.57	N/A
Brainsway	$52.22M	11.57	$7.57M	$0.35	43.03

Avita Medical currently has a consensus target price of $7.25, suggesting a potential upside of 78.57%. Brainsway has a consensus target price of $16.00, suggesting a potential upside of 6.24%. Given Avita Medical's higher possible upside, analysts clearly believe Avita Medical is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
Brainsway	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Avita Medical has a beta of 1.86, indicating that its stock price is 86% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Brainsway has a net margin of 15.68% compared to Avita Medical's net margin of -62.67%. Brainsway's return on equity of 12.28% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
Brainsway	15.68%	12.28%	7.75%

In the previous week, Brainsway had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for Brainsway and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.25 beat Brainsway's score of 0.63 indicating that Avita Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Avita Medical	Positive
Brainsway	Positive

Summary

Brainsway beats Avita Medical on 11 of the 16 factors compared between the two stocks.

How does Avita Medical compare to MiMedx Group?

MiMedx Group (NASDAQ:MDXG) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

79.2% of MiMedx Group shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 2.5% of MiMedx Group shares are held by insiders. Comparatively, 2.8% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, MiMedx Group and MiMedx Group both had 1 articles in the media. MiMedx Group's average media sentiment score of 1.89 beat Avita Medical's score of 1.25 indicating that MiMedx Group is being referred to more favorably in the media.

Company	Overall Sentiment
MiMedx Group	Very Positive
Avita Medical	Positive

MiMedx Group has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than MiMedx Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiMedx Group	$418.63M	1.46	$48.58M	$0.20	20.55
Avita Medical	$71.61M	1.75	-$48.59M	-$1.57	N/A

MiMedx Group currently has a consensus target price of $8.50, indicating a potential upside of 106.81%. Avita Medical has a consensus target price of $7.25, indicating a potential upside of 78.57%. Given MiMedx Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe MiMedx Group is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiMedx Group	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

MiMedx Group has a net margin of 7.88% compared to Avita Medical's net margin of -62.67%. MiMedx Group's return on equity of 21.03% beat Avita Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiMedx Group	7.88%	21.03%	15.92%
Avita Medical	-62.67%	N/A	-78.92%

MiMedx Group has a beta of 1.45, indicating that its share price is 45% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market.

Summary

MiMedx Group beats Avita Medical on 12 of the 15 factors compared between the two stocks.

How does Avita Medical compare to NeuroPace?

NeuroPace (NASDAQ:NPCE) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

78.8% of NeuroPace shares are owned by institutional investors. Comparatively, 27.7% of Avita Medical shares are owned by institutional investors. 20.5% of NeuroPace shares are owned by insiders. Comparatively, 2.8% of Avita Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

NeuroPace has higher revenue and earnings than Avita Medical. NeuroPace is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroPace	$99.99M	5.83	-$21.47M	-$0.65	N/A
Avita Medical	$71.61M	1.75	-$48.59M	-$1.57	N/A

In the previous week, NeuroPace had 2 more articles in the media than Avita Medical. MarketBeat recorded 3 mentions for NeuroPace and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.25 beat NeuroPace's score of 0.97 indicating that Avita Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
NeuroPace	Positive
Avita Medical	Positive

NeuroPace has a net margin of -21.67% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroPace	-21.67%	-108.20%	-18.50%
Avita Medical	-62.67%	N/A	-78.92%

NeuroPace presently has a consensus price target of $18.83, indicating a potential upside of 10.07%. Avita Medical has a consensus price target of $7.25, indicating a potential upside of 78.57%. Given Avita Medical's higher possible upside, analysts clearly believe Avita Medical is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

NeuroPace has a beta of 1.88, indicating that its share price is 88% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market.

Summary

NeuroPace beats Avita Medical on 12 of the 16 factors compared between the two stocks.

How does Avita Medical compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

30.1% of ClearPoint Neuro shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 6.9% of ClearPoint Neuro shares are held by insiders. Comparatively, 2.8% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ClearPoint Neuro has higher earnings, but lower revenue than Avita Medical. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	14.20	-$25.54M	-$1.01	N/A
Avita Medical	$71.61M	1.75	-$48.59M	-$1.57	N/A

ClearPoint Neuro currently has a consensus price target of $23.00, suggesting a potential upside of 31.43%. Avita Medical has a consensus price target of $7.25, suggesting a potential upside of 78.57%. Given Avita Medical's stronger consensus rating and higher possible upside, analysts clearly believe Avita Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Avita Medical has a net margin of -62.67% compared to ClearPoint Neuro's net margin of -71.57%. Avita Medical's return on equity of 0.00% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Avita Medical	-62.67%	N/A	-78.92%

ClearPoint Neuro has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market.

In the previous week, ClearPoint Neuro and ClearPoint Neuro both had 1 articles in the media. ClearPoint Neuro's average media sentiment score of 1.87 beat Avita Medical's score of 1.25 indicating that ClearPoint Neuro is being referred to more favorably in the media.

Company	Overall Sentiment
ClearPoint Neuro	Very Positive
Avita Medical	Positive

Summary

Avita Medical beats ClearPoint Neuro on 8 of the 15 factors compared between the two stocks.

How does Avita Medical compare to OrthoPediatrics?

Avita Medical (NASDAQ:RCEL) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are owned by institutional investors. 2.8% of Avita Medical shares are owned by insiders. Comparatively, 32.7% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Avita Medical presently has a consensus target price of $7.25, suggesting a potential upside of 78.57%. OrthoPediatrics has a consensus target price of $24.44, suggesting a potential upside of 20.24%. Given Avita Medical's higher possible upside, equities analysts plainly believe Avita Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

Avita Medical has a beta of 1.86, suggesting that its share price is 86% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market.

OrthoPediatrics has higher revenue and earnings than Avita Medical. OrthoPediatrics is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.75	-$48.59M	-$1.57	N/A
OrthoPediatrics	$236.35M	2.21	-$39.65M	-$1.68	N/A

In the previous week, Avita Medical and Avita Medical both had 1 articles in the media. OrthoPediatrics' average media sentiment score of 1.87 beat Avita Medical's score of 1.25 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Overall Sentiment
Avita Medical	Positive
OrthoPediatrics	Very Positive

OrthoPediatrics has a net margin of -16.31% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

Summary

OrthoPediatrics beats Avita Medical on 10 of the 15 factors compared between the two stocks.

Get Avita Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RCEL vs. The Competition

Export

Metric	Avita Medical	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$135.73M	$3.12B	$7.14B	$12.64B
Dividend Yield	N/A	2.06%	2.68%	7.83%
P/E Ratio	-2.59	20.02	27.42	24.58
Price / Sales	1.75	860.64	593.42	122.69
Price / Cash	N/A	57.45	49.34	60.04
Price / Book	-7.38	4.29	10.88	6.38
Net Income	-$48.59M	$64.65M	$3.59B	$331.87M
7 Day Performance	-19.76%	-0.75%	-0.26%	0.37%
1 Month Performance	2.27%	4.48%	4.52%	0.53%
1 Year Performance	-28.77%	24.70%	29.17%	21.96%

Avita Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RCEL Avita Medical	4.0845 of 5 stars	$4.06 -7.9%	$7.25 +78.6%	-31.6%	$135.73M	$71.61M	N/A	130	Positive News
BWAY Brainsway	2.8601 of 5 stars	$15.27 -4.7%	$16.00 +4.8%	+138.3%	$612.58M	$52.22M	43.62	120
MDXG MiMedx Group	3.7236 of 5 stars	$4.11 +1.0%	$8.50 +106.9%	-39.4%	$611.44M	$418.63M	20.53	870
NPCE NeuroPace	1.9542 of 5 stars	$17.37 +0.3%	$18.83 +8.4%	+68.2%	$600.15M	$99.99M	N/A	170	News Coverage
CLPT ClearPoint Neuro	3.7502 of 5 stars	$17.47 -2.9%	$23.00 +31.6%	+46.3%	$524.41M	$36.97M	N/A	110

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RCEL) was last updated on 7/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avita Medical (RCEL) Competitors

RCEL vs. BWAY, MDXG, NPCE, CLPT, and KIDS

How does Avita Medical compare to Brainsway?

Summary

How does Avita Medical compare to MiMedx Group?

Summary

How does Avita Medical compare to NeuroPace?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Summary

How does Avita Medical compare to OrthoPediatrics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Avita Medical (RCEL) Competitors

RCEL vs. BWAY, MDXG, NPCE, CLPT, and KIDS

How does Avita Medical compare to Brainsway?

Which has preferable earnings and valuation, RCEL or BWAY?

Do analysts prefer RCEL or BWAY?

Which has more volatility and risk, RCEL or BWAY?

Do institutionals & insiders have more ownership in RCEL or BWAY?

Is RCEL or BWAY more profitable?

Does the media favor RCEL or BWAY?

Summary

How does Avita Medical compare to MiMedx Group?

Do institutionals & insiders believe in MDXG or RCEL?

Does the media refer more to MDXG or RCEL?

Which has higher valuation & earnings, MDXG or RCEL?

Do analysts recommend MDXG or RCEL?

Is MDXG or RCEL more profitable?

Which has more volatility and risk, MDXG or RCEL?

Summary

How does Avita Medical compare to NeuroPace?

Do institutionals and insiders believe in NPCE or RCEL?

Which has higher valuation and earnings, NPCE or RCEL?

Does the media favor NPCE or RCEL?

Is NPCE or RCEL more profitable?

Do analysts recommend NPCE or RCEL?

Which has more risk & volatility, NPCE or RCEL?

Summary

How does Avita Medical compare to ClearPoint Neuro?

Do institutionals & insiders have more ownership in CLPT or RCEL?

Which has higher earnings & valuation, CLPT or RCEL?

Do analysts prefer CLPT or RCEL?

Is CLPT or RCEL more profitable?

Which has more risk and volatility, CLPT or RCEL?

Does the media prefer CLPT or RCEL?

Summary

How does Avita Medical compare to OrthoPediatrics?

Do institutionals and insiders hold more shares of RCEL or KIDS?

Do analysts recommend RCEL or KIDS?

Which has more volatility and risk, RCEL or KIDS?

Which has preferable valuation and earnings, RCEL or KIDS?

Does the media refer more to RCEL or KIDS?

Is RCEL or KIDS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RCEL vs. The Competition

Avita Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools